ZURICH, Nov 24 (Reuters) - The following are some of the
main factors expected to affect Swiss stocks on Tuesday:
NOVARTIS NOVN.VX
The European Commission has approved Novartis' Entresto drug
for the treatment of adult patients with symptomatic chronic
heart failure with reduced ejection fraction, the Swiss
drugmaker said. urn:newsml:reuters.com:*:nFWN13I01P
For more click on NOVN.VX
COMPANY STATEMENTS CPR-CH
* COMET Group COTN.S said it plans to grow sales to 500
million Swiss francs ($490.97 million) by 2020 with an EBITDA
margin of 16-18 percent. The company is presenting its Strategy
2020 at the group's 2015 investor day. COTN.S
* Morgan Stanley MS.N has hired a team of private wealth
advisers from Credit Suisse CSGN.VX in New York, Bloomberg
reported, citing an e-mailed statement from Morgan Stanley.
CSGN.VX
* Leonteq LEON.S said it was informed of a number of
concurrent transactions related to its shares urn:newsml:reuters.com:*:nFWN13I045. It
was also informed by Raiffeisen Switzerland Cooperative of the
results of its placement of Leonteq shares held by its
subsidiary, Notenstein La Roche Private Bank. LEON.S
* Cembra Money Bank CMBN.S said Chief Financial Officer
Antoine Boublil has decided to leave the company to be CFO of
the Swiss Universal Bank Division of Credit Suisse. CMBN.S
* lastminute.com LMN.S announced a partnership with Bat
Sharing, an urban mobility app. It is now the major shareholder
of URBANnext SA, which operates Bat Sharing. LMN.S
* Partners Group PGHN.S said it had completed its
acquisition of a minority stake in China-based retailer
Aiyingshi. PGHN.S
* Cicor CICN.S said it was taking targeted measures for
the strategic orientation of the group. In future, it aims to
generate an EBITDA margin over 10 percent. CICN.S
ECONOMY M-CH
* Third-quarter data for non-farm payrolls, which had been
due on Tuesday, will be delayed as a result changes to the
formula by the Federal Statistics Office. It hopes to be able to
release provisional figures in 2015.
RATINGS
* Credit Suisse CSGN.VX : JP Morgan cuts target price to 28
francs from 30 francs; rating overweight
* Richemont SA CFR.VX : Nomura cuts price target to 90
francs from 92 francs.
* Swatch UHR.VX : Nomura cuts target price to 410 francs
from 460 francs.
($1 = 1.0184 Swiss francs)
(Reporting by Zurich newsroom)
((+41 58 306 7336)(zurich.newsroom@thomsonreuters.com))
((For Top News in a multimedia Web format on Eikon visit:
https://emea1.views.cp.extranet.thomsonreuters.biz/Explorer/NEWSxTOPNEWS.aspx?group=SP_GROUP_001&page=SP_PAGE_001&pageName=FrontPage
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German................ .SDE
All SMI constituent stocks............................ 0#.SSMI
News on major Swiss stock price moves.................. CH-HOT
FTSE Eurotop 300 index................................ .FTEU3
DJ STOXX index........................................ .STOXX
Top 10 STOXX sectors............................. .PGL.STOXXS
Top 10 EUROSTOXX sectors........................ .PGL.STOXXES
Top 10 Eurotop 300 sectors....................... .PGL.FTEU3S
Top 25 European pct gainers... .PG.PEUR , losers... .PL.PEUR
Swiss mid-cap index .SSMI SMI futures 0#SMI:
Swiss all-share index .SSHI Market statistics CH/STATS1
Swiss market digest .AD.S Sector overview CH/SECTOR1
All Swiss news CH Swiss diary CH/DIARY
Swiss research news CH-RCH Virt-x sectors VX/SECTOR1
All equity news E Virt-x price index .VMIP
INTERNET ADDRESSES: Virt-x www.virt-x.com
Swiss Exchange www.swx.ch/
Eurex www.eurexchange.com
STOXX Ltd www.stoxx.com
SPEED GUIDES: VX/EQUITY EQUITY EQUITY/NEWS1 EUR/EQUITY
SWITZERLAND REUTERS ))
Keywords: MARKETS SWISS STOCKS/